MicroRNA-221 and -222 pathway controls melanoma progression.
about
Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cellsThe regulation of miRNA-211 expression and its role in melanoma cell invasiveness.Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanomaMicroRNA in Melanoma.MicroRNAs in skin and wound healing.MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathwaysEpigenetic mechanisms in commonly occurring cancers.Serum microRNAs as biomarkers for recurrence in melanoma.Genome-wide methylated CpG island profiles of melanoma cells reveal a melanoma coregulation networkSystems analysis identifies miR-29b regulation of invasiveness in melanoma.Role of miRNAs in the progression of malignant melanoma.Genetics of uveal melanoma and cutaneous melanoma: two of a kind?MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.Molecular and cellular pathogenesis of melanoma initiation and progression.miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.Epigenetics of melanoma: implications for immune-based therapies.Immunomodulation of malignant melanoma by contact sensitizing agents.TH17 is involved in the remarkable regression of metastatic malignant melanoma to topical diphencyprone.miRNAs in melanoma: a defined role in tumor progression and metastasis.Mir-221/222 are promising targets for innovative anticancer therapy.MicroRNAs role as potential biomarkers and key regulators in melanoma.Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.Clinical potential of miRNA-221 as a novel prognostic biomarker for hepatocellular carcinoma.MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.
P2860
Q24321272-4F51DBC1-0E06-4826-9AD0-571D4B8C7E59Q33745034-E6DD53DF-56D5-4F02-922E-9295C826A51BQ33808094-379C1A00-57A5-47FA-A171-37E2CBD8B28FQ34459058-C21933A5-E867-4DEC-B57E-12BFCD44B0DBQ34986222-B9FAF9EA-60F9-42A7-A31A-2417928DDFF9Q35033659-0A4E9736-FA94-49F2-B562-49384F416126Q35930474-A8896DCF-1FB3-4B2F-A9F0-3596742B01BCQ36286662-860EBB9C-FD89-4733-B56D-71B2BB29F51DQ36341127-D9FDDCFF-5051-434E-9883-A0952B52C3F5Q37231658-D7E8BD5B-3A18-437A-85C9-8C60B564B553Q37419437-F8C43FA7-18A7-41B9-AF6E-39B2108AC4E6Q37565026-A7333CD4-20F6-49B5-835E-0D43A3C79A45Q37772777-F1E3DCA0-BB83-43F8-B9C3-FA844E250CD1Q38018308-58A88DE3-F866-4206-9479-4004F5CDD782Q38093446-734B4A63-9701-4B56-ABFE-A41DC6B0E180Q38138933-7CF99C73-4028-464F-9073-0961318DC90AQ38148588-B9F97AD1-37C4-45B4-82F0-8417863816CBQ38168949-BC7D8941-E0BE-49A5-9A00-E475EB2DBD18Q38543791-9B34D360-D909-4F5A-98FB-E914E4A1580DQ38617229-3144E5BD-B33D-40C4-87BD-2F621D49E169Q38767024-2DF69324-2756-4796-8638-350E8EAFC04DQ38937088-59B8EA14-B28F-4881-92FE-AFBE9EAE4627Q39398949-B89B35A5-DCEB-47E0-A58B-DB12CE38F852Q39514244-27D8A50F-1BA3-4B43-88EA-E2A0C91E79CEQ40421679-0026AB74-6627-47A2-B157-45D1695E7963Q50062795-DDF2CAFE-384D-409B-8240-3FAD7553961F
P2860
MicroRNA-221 and -222 pathway controls melanoma progression.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
MicroRNA-221 and -222 pathway controls melanoma progression.
@ast
MicroRNA-221 and -222 pathway controls melanoma progression.
@en
type
label
MicroRNA-221 and -222 pathway controls melanoma progression.
@ast
MicroRNA-221 and -222 pathway controls melanoma progression.
@en
prefLabel
MicroRNA-221 and -222 pathway controls melanoma progression.
@ast
MicroRNA-221 and -222 pathway controls melanoma progression.
@en
P2860
P50
P1476
MicroRNA-221 and -222 pathway controls melanoma progression.
@en
P2093
M Cristina Errico
Patrizia Segnalini
P2860
P304
P356
10.1586/14737140.8.11.1759
P577
2008-11-01T00:00:00Z